Vizient forecasts a 3.84% rise in pharmacy spending for health systems and ambulatory surgery centers, driven by specialty and personalized medicines.

Viralgen and Axovia Therapeutics are partnering to advance the development and manufacture of an AAV9-based investigational gene therapy aimed at treating retinal dystrophy in patients with ...

In a phase IIb/III trial of linsitinib for moderate to severe thyroid eye disease, treatment with the highest dose of the investigational, oral insulin-like growth factor 1 receptor inhibitor ...